Temporal Relationships Between Esophageal Injury Type and Progression in Patients Undergoing Atrial Fibrillation Catheter Ablation
Overview
Authors
Affiliations
Background: Currently, little is known about the onset, natural progression, and management of esophageal injuries after atrial fibrillation (AF) ablation.
Objectives: We sought to provide a systematic review on esophageal injury after AF ablation and identify temporal relationships between various types of esophageal lesions, their progression, and clinical outcomes.
Methods: A comprehensive search of PubMed and Web of Science was conducted until September 21, 2017. All AF ablation patients who underwent upper gastrointestinal endoscopy within 1 week of the procedure were included. Patients with esophageal lesions were classified into 3 types by using our novel Kansas City classification: type 1: erythema; type 2a: superficial ulcers; type 2b: deep ulcers; type 3a: perforation without communication with the atria; and type 3b: perforation with atrioesophageal fistula.
Results: Thirty studies met our inclusion criteria. Of the 4473 patients, 3921 underwent upper gastrointestinal evaluation. The overall incidence of esophageal injuries was 15% (570). There were 206 type 1 lesions (36%), 222 type 2a lesions (39%), and 142 type 2b lesions (25%). Six of 142 type 2b lesions (4.2%) progressed further to type 3, of which, 5 were type 3a and 1 was type 3b. All type 1 and type 2a and most type 2b lesions resolved with conservative management. One type 3a and 1 type 3b lesions were fatal.
Conclusion: Based on our classification, all type 1 and most type 2 lesions resolved with conservative management. A small percentage (4.2% [6 of 142]) of type 2b lesions progressed to perforation and/or fistula formation, and these patients need to be followed closely.
Surveillance of esophageal injury after atrial fibrillation catheter ablation.
Ferraz A, Pisani C, Rivarola E, Wu T, Darrieux F, Scanavacca R J Interv Card Electrophysiol. 2024; .
PMID: 39436462 DOI: 10.1007/s10840-024-01922-8.
Zimmeck H, Deneke T, Halm U, Zachaus M, Nedios S Eur Heart J Case Rep. 2024; 8(10):ytae534.
PMID: 39421456 PMC: 11483625. DOI: 10.1093/ehjcr/ytae534.
Erkapic D, Roussopoulos K, Aleksic M, Sozener K, Kostev K, Rosenbauer J Diagnostics (Basel). 2024; 14(13).
PMID: 39001260 PMC: 11241260. DOI: 10.3390/diagnostics14131370.
To monitor, or not to monitor, that is the question.
Agarwal R, Mahajan R Indian Pacing Electrophysiol J. 2024; 24(4):189-191.
PMID: 38997110 PMC: 11361891. DOI: 10.1016/j.ipej.2024.07.003.
Almorad A, Del Monte A, Teumer Y, El Haddad M, Pannone L, Della Rocca D J Clin Med. 2023; 12(19).
PMID: 37834900 PMC: 10573603. DOI: 10.3390/jcm12196256.